Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
about
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewUsing the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessInfluenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological ActivityModel-based simulation and prediction of an antiviral strategy against influenza A infection.Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.Clinical use of approved influenza antivirals: therapy and prophylaxis.Emerging antiviral strategies to interfere with influenza virus entry.New treatments for influenzaInhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design.Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokineticsA Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Optimizing antiviral therapy for influenza: understanding the evidence.Development of a magnetic electrochemical bar code array for point mutation detection in the H5N1 neuraminidase gene.
P2860
Q26749578-F698CB9E-FDCE-4B61-9631-9D11F5C2729AQ26860032-CB05675F-E9EB-47ED-8686-316CC790DEADQ27000668-CEA6CB94-1C16-47CC-A189-03036093B85BQ28079041-09102CC3-D4AB-423F-9500-D4D3D952EBADQ30352246-3A851316-4E42-489F-A7B1-FFE2296306FEQ30357189-C4B42760-CDDC-454A-9EF2-51B7AD7291C3Q30362700-EE82A42A-3ADA-406B-BA4D-79E70CB5EB3EQ30425343-BA928849-D442-414D-A869-C32615FC6C72Q30432421-23D56E95-A685-4FA9-B2EA-BDFD1F55DE4EQ34413797-5DE8ECF1-927B-4926-B6B2-96415E793E0BQ35996541-5816896D-6ED7-4222-8D67-F22A69E430F4Q36924693-6A0D66AF-0604-4784-ABE5-F96AF89D4409Q37549382-FC97C30B-9E56-447F-A67F-E1EE5B7BC95EQ38209673-650FFC88-2678-4F39-870C-8E0974CA0A01Q38361244-BB681D23-95FD-4902-95D7-C519307D7545Q42283472-591A9F62-29B1-4F96-8648-5B1D4BE4AA27
P2860
Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
@en
type
label
Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
@en
prefLabel
Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
@en
P2860
P356
P1476
Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
@en
P2093
Kalayanee Chairat
Niklas Lindegardh
P2860
P304
P356
10.1177/0091270012440280
P577
2013-01-24T00:00:00Z